Why Pfizer Is Pulling Back again on Exploration Into Unusual Condition, Gene Treatment
Pfizer is preparing to pull again on early-phase research into treatments for exceptional illnesses, which include ...
Read morePfizer is preparing to pull again on early-phase research into treatments for exceptional illnesses, which include ...
Read moreA further large nontraded serious estate fund is limiting investor redemptions. Starwood Real Estate Cash flow ...
Read moreIdaira Chavez is just the sort of vehicle purchaser that BlackRock new social-impact fund could possibly ...
Read more